← Leaderboards
Susan E Gueble
Yale University
$1,256,250
Attributed
$1,256,250
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $418.8K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,256,250 · 1
By mechanism
DP5$1,256,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Peter M Glazer$37,467,142
- Rajni Mehta$1,413,974
- Ranjit Bindra$5,884,099
- Seth B. Herzon$10,471,068
- Ravinder Nath$4,400,240
Others in their field
Other Rising Stars on “Alkylating Agents”
- Paul Tang · University Of Michigan At Ann Arbor$2,648,134
- Philipp Oberdoerffer · Johns Hopkins University$1,068,067
- Sarah R Hengel · University Of Pittsburgh At Pittsburgh$963,086
- Spencer Pitre · Oklahoma State University Stillwater$728,012
- John Walter Glod · University Of California, San Diego$593,704
- Graham E Dobereiner · Temple University$477,048
Research focus
Alkylating AgentsAnimal FacilityAwardBasic ScienceBioinformaticsBiologyCancer CareCancer HistologyCancer PatientCancer TypeCell LineCell ModelCellsClinically RelevantClinical PredictorsClinical TrialsCollaborationsCollaborative EnvironmentColon CarcinomaCombined Modality TherapyCrispr ScreenCrosslinkCytotoxicityAbnormal Dna Repair
Grant awards (3)
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer$418,750
DP5 · FY2025 · OD · contact PI
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer$418,750
DP5 · FY2024 · OD · contact PI
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer$418,750
DP5 · FY2023 · OD · contact PI